Key Highlights

  • IDEX's $0.73 regular quarterly dividend, its 128th consecutive, has an October 2, 2026 ex-dividend date and is payable October 16.
  • Second-quarter net sales were a record $920.6 million, up 6% reported and 5% organically, and orders were a record $1,071.6 million.
  • Reported diluted EPS was $1.93, up 11%, and adjusted diluted EPS, a non-GAAP measure, was a record $2.32, up 12%.
  • The company returned $77 million through share repurchases and $54 million through dividends, and raised 2026 organic growth and adjusted EPS guidance.

Overview

IDEX Corporation's (NYSE:IEX) $0.73 regular quarterly dividend yields 1.27% and sits beside second-quarter reported diluted EPS of $1.93 and adjusted diluted EPS of $2.32. Approved on September 16, 2026, it is the company's 128th consecutive regular quarterly cash dividend, at the same $0.73 approved in May and June 2026.

Dividend Program and Shareholder Returns

IDEX's Board approved a regular quarterly cash dividend of $0.73 per common share on September 16, 2026. It is payable October 16 to shareholders of record as of October 2, and represents the company's 128th consecutive regular quarterly cash dividend payment.

The 126th dividend, $0.73, was approved May 6 and paid June 5. The 127th, $0.73, was approved June 17 and paid July 24 to shareholders of record July 6.

About the Company

IDEX is a global engineered products company with three primary segments: Health & Science Technologies, Fluid & Metering Technologies, and Fire & Safety / Diversified Products. Founded in 1988 and based in Northbrook, Illinois, it includes more than 50 businesses and manufacturing operations in more than 20 countries.

Financial Performance Behind the Payout

IDEX reported second-quarter net sales of $920.6 million versus $865.4 million. Gross profit was $426.8 million, a gross margin of 46.3%, and operating income was $199.9 million. Net income attributable to IDEX was $143.4 million versus $131.6 million, and reported diluted EPS was $1.93 versus $1.74.

Adjusted diluted EPS was $2.32 versus $2.07. Adjusted EBITDA, a non-GAAP measure, was $258.3 million, with a margin of 28.1%, up 70 basis points. Orders were $1,071.6 million, up 29% reported and 28% organically. Health & Science Technologies orders rose 47%, Fluid & Metering Technologies 11%, and Fire & Safety / Diversified Products 19%.

Tariff Refunds Reported Within Second-Quarter Results

IDEX collected substantially all anticipated refunds of previously paid IEEPA tariffs in the second quarter. The refunds produced a $22.0 million reduction in cost of sales and a $14.7 million reduction in net sales from expected customer rebates.

The company said the net impact benefited both reported and adjusted diluted EPS by $0.08 and benefited margin by 120 basis points in the quarter.

Outlook

IDEX raised 2026 guidance to adjusted diluted EPS of $8.70 to $8.85 from $8.35 to $8.55, organic sales growth of 5% to 6% from 3% to 4%, and adjusted EBITDA margin of 27.0% to 27.3% from 26.5% to 27.0%. Order conversion to sales, data center and semiconductor demand cited by management, and the tariff refund items are the measures reported alongside that guidance.